4.7 Review

Mitochondrial Syndromes Revisited

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/jcm10061249

Keywords

CPEO; leber; Leigh syndrome; MELAS; MERRF; mitochondrial myopathy; MNGIE; mtDNA; NARP; PEO

Funding

  1. Telethon Grant [GUP09004]
  2. Telethon-MITOCON Grant [GSP16001]
  3. GENOMIT [RF-2016-02361495]

Ask authors/readers for more resources

In the last decade, knowledge of the genetic basis of mitochondrial diseases has significantly advanced. Despite specific genetic alterations being associated with certain syndromic presentations, the genotype-phenotype relationship in mitochondrial disorders remains complex.
In the last ten years, the knowledge of the genetic basis of mitochondrial diseases has significantly advanced. However, the vast phenotypic variability linked to mitochondrial disorders and the peculiar characteristics of their genetics make mitochondrial disorders a complex group of disorders. Although specific genetic alterations have been associated with some syndromic presentations, the genotype-phenotype relationship in mitochondrial disorders is complex (a single mutation can cause several clinical syndromes, while different genetic alterations can cause similar phenotypes). This review will revisit the most common syndromic pictures of mitochondrial disorders, from a clinical rather than a molecular perspective. We believe that the new phenotype definitions implemented by recent large multicenter studies, and revised here, may contribute to a more homogeneous patient categorization, which will be useful in future studies on natural history and clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease

Alberto Giannoni, Alberto Aimo, Michelangelo Mancuso, Massimo Francesco Piepoli, Daniele Orsucci, Giovanni Donato Aquaro, Andrea Barison, Daniele De Marchi, Claudia Taddei, Matteo Cameli, Valentina Raglianti, Gabriele Siciliano, Claudio Passino, Michele Emdin

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Article Clinical Neurology

Revisiting mitochondrial ocular myopathies: a study from the Italian Network

D. Orsucci, C. Angelini, E. Bertini, V. Carelli, G. P. Comi, A. Federico, C. Minetti, M. Moggio, T. Mongini, F. M. Santorelli, S. Servidei, P. Tonin, A. Ardissone, L. Bello, C. Bruno, E. Caldarazzo Ienco, D. Diodato, M. Filosto, C. Lamperti, I. Moroni, O. Musumeci, E. Pegoraro, G. Primiano, D. Ronchi, A. Rubegni, S. Salvatore, M. Sciacco, M. L. Valentino, L. Vercelli, A. Toscano, M. Zeviani, G. Siciliano, M. Mancuso

JOURNAL OF NEUROLOGY (2017)

Editorial Material Medicine, General & Internal

Revealing the Complexity of Mitochondrial DNA-Related Disorders

Daniele Orsucci, Gabriele Siciliano, Michelangelo Mancuso

EBIOMEDICINE (2018)

Article Clinical Neurology

Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients

Olimpia Musumeci, Emanuele Barca, Costanza Lamperti, Serenella Servidei, Giacomo Pietro Comi, Maurizio Moggio, Tiziana Mongini, Gabriele Siciliano, Massimiliano Filosto, Elena Pegoraro, Guido Primiano, Dario Ronchi, Liliana Vercelli, Daniele Orsucci, Luca Bello, Massimo Zeviani, Michelangelo Mancuso, Antonio Toscano

FRONTIERS IN NEUROLOGY (2019)

Letter Clinical Neurology

Type-1 neurofibromatosis mimicking multiple mononeuropathy: the help of nerve ultrasound

Daniele Orsucci, Gianluca Moscato, Vincenzo Ricci, Stefano Galletti, Marco Vista

NEUROLOGICAL SCIENCES (2021)

Article Medicine, General & Internal

Increased Creatine Kinase May Predict A Worse COVID-19 Outcome

Daniele Orsucci, Michele Trezzi, Roberto Anichini, Pierluigi Blanc, Leandro Barontini, Carlo Biagini, Alessandro Capitanini, Marco Comeglio, Paulo Corsini, Federico Gemignani, Roberto Giannecchini, Massimo Giusti, Mario Lombardi, Elena Marrucci, Alessandro Natali, Gabriele Nenci, Franco Vannucci, Gino Volpi

Summary: The study showed that serum levels of the muscular enzyme creatine-(phospho)-kinase (CK/CPK) in COVID-19 patients at admission were associated with disease severity, with hyperCKemia >200 U/L linked to worse prognosis. The elevated CK levels acted as an independent predictor for severe outcomes; however, hyperCKemia was generally transient and returned to normal during hospitalization in most patients. While direct infection of voluntary muscle by the novel coronavirus remains unproven, transient muscular dysfunction is common during the course of COVID-19.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases

Chiara Ticci, Daniele Orsucci, Anna Ardissone, Luca Bello, Enrico Bertini, Irene Bonato, Claudio Bruno, Valerio Carelli, Daria Diodato, Stefano Doccini, Maria Alice Donati, Claudia Dosi, Massimiliano Filosto, Chiara Fiorillo, Chiara La Morgia, Costanza Lamperti, Silvia Marchet, Diego Martinelli, Carlo Minetti, Maurizio Moggio, Tiziana Enrica Mongini, Vincenzo Montano, Isabella Moroni, Olimpia Musumeci, Elia Pancheri, Elena Pegoraro, Guido Primiano, Elena Procopio, Anna Rubegni, Roberta Scalise, Monica Sciacco, Serenella Servidei, Gabriele Siciliano, Costanza Simoncini, Deborah Tolomeo, Paola Tonin, Antonio Toscano, Flavia Tubili, Michelangelo Mancuso, Roberta Battini, Filippo Maria Santorelli

Summary: Movement disorders are increasingly recognized as a manifestation of childhood-onset mitochondrial diseases. This study retrospectively explored a cohort of individuals with childhood-onset MDs and found that most patients experienced a worsening of their movement disorder during the disease course. The most commonly associated neuroradiological patterns included basal ganglia involvement, cerebral white matter changes, and cerebellar atrophy. Genetic mutations were diverse, and pharmacological treatment mainly involved clonazepam and oral baclofen.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

The Diagnostic Approach to Mitochondrial Disorders in Children in the Era of Next-Generation Sequencing: A 4-Year Cohort Study

Deborah Tolomeo, Daniele Orsucci, Claudia Nesti, Jacopo Baldacci, Roberta Battini, Claudio Bruno, Giorgia Bruno, Denise Cassandrini, Stefano Doccini, M. Alice Donati, Annarita Ferrari, Simona Fiori, Chiara Fiorillo, Renzo Guerrini, Francesco Mari, Martino Montomoli, Francesca Pochiero, Elena Procopio, Lucia Ruggiero, Simone Sampaolo, Federico Sicca, Chiara Ticci, Anna Rubegni, Filippo M. Santorelli

Summary: Mitochondrial diseases (MDs) are a group of genetically determined multisystem disorders characterized by diagnostic challenges and a lack of genetic studies. Neuroimaging evidence of basal ganglia (BG) involvement and psychomotor regression are important predictors for diagnosing MD.

JOURNAL OF CLINICAL MEDICINE (2021)

Editorial Material Medicine, General & Internal

Mitochondrial Medicine in the COVID-19 Era

Daniele Orsucci

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective

Daniele Orsucci, Lucia Lorenzetti, Fulvia Baldinotti, Andrea Rossi, Edoardo Vitolo, Fabio Luigi Gheri, Alessandro Napolitano, Giancarlo Tintori, Marco Vista

Summary: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a premutation in the FMR1 gene. In females, FXTAS has a broad spectrum of symptoms ranging from relatively severe cases starting in mid-adulthood to mild cases beginning in later life.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, Research & Experimental

Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)

Antonella Bacchieri, Andrea Rossi, Paolo Morelli

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2020)

Article Neurosciences

Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges

Bruno Dubois, Alessandro Padovani, Philip Scheltens, Andrea Rossi, Grazia Dell'Agnello

JOURNAL OF ALZHEIMERS DISEASE (2016)

No Data Available